PACAP-38 induces neuronal differentiation of human SH-SY5Y neuroblastoma cells via cAMP-mediated activation of ERK and p38 MAP kinases

Journal of Neurochemistry

Volumn 104, Issue 1, 2008, Pages 74-88

  Monaghan, T K ^a   MacKenzie, C J ^a   Plevin, R ^a   Lutz, E M ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

cAMP dependent; Epac; Neuritogenesis; PAC1 receptor; PACAP; VIP

Indexed keywords

2',5' DIDEOXYADENOSINE; ADENYLATE CYCLASE INHIBITOR; CHOLINE ACETYLTRANSFERASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1;

ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVE SITE; NERVE CELL DIFFERENTIATION; NEURITE; NEUROBLASTOMA CELL; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

CELL SIZE; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH SUBSTANCES; HUMANS; NERVE TISSUE PROTEINS; NEUROBLASTOMA; NEURONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; VASOACTIVE INTESTINAL PEPTIDE;

EID: 37249046004     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.05018.x     Document Type: Article

References (72)

1. Alleaume C., Eychène A., Harnois T., Bourmeyster N., Constantin B., Caigneaux E., Muller J.-M. Philippe M. (2004) Vasoactive intestinal peptide-induced neurite remodeling in human neuroblastoma SH-SY5Y cells implicates the cdc42 GTPase and is independent of Ras-ERK pathway. Exp. Cell Res. 299, 511 524.
2. Boeshore K. L., Schreiber R. C., Vaccariello S. A., Sachs H. H., Salazar R., Lee J., Ratan R. R., Leahy P. Zigmond R. E. (2004) Novel changes in gene expression following axotomy of a sympathetic ganglion: a microarray analysis. J. Neurobiol. 59, 216 235.
3. Borba J. C., Henze I. P., Silveira M. S., Kubrusly R. C., Gardino P. F., de Mello M. C., Hokoc J. N. de Mello F. G. (2005) Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development. Brain Res. Dev. Brain Res. 156, 193 201.
4. Boudreau R. T. M., Hoskin D. W. Lin T.-J. (2004) Phosphatase inhibition potentiates IL-6 production by mast cells in response to FcεRI-mediated activation: involvement of p38 MAPK. J. Leukoc. Biol. 76, 1075 1081.
5. Braas K. M. May V. (1996) Pituitary adenylate cyclase-activating polypeptides, PACAP-38 and PACAP-27, regulation of sympathetic neuron catecholamine, and neuropeptide Y expression through activation of type I PACAP/VIP receptor isoforms. Ann. NY Acad. Sci. 805, 204 216.
6. Buttiglione M., Vitiello F., Sardella E., Petrone L., Nardulli M., Favia P., d'Agostino R. Gristina R. (2007) Behaviour of SH-SY5Y neuroblastoma cell line grown in different media and on different chemically modified substrates. Biomaterials 28, 2932 2945.
7. Chen C.-H., Zhang D.-H., LaPorte J. M. Ray A. (2000) Cyclic AMP activates p38 Mitogen-Activated Protein Kinase in Th2 cells: phosphorylation of GATA-3 and stimulation of Th2 cytoline gene expression. J. Immunol. 165, 5597 5605.
8. Chen Y., Samal B., Hamelink C. R., Xiang C. C., Chen M., Vaudry D., Brownstein M. J., Hallenbeck J. M. Eiden L. E. (2006) Neuroprotection by endogenous and exogenous PACAP following stroke. Regul. Pept. 137, 4 19.
9. Davies S. P., Reddy H., Caivano M. Cohen P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95 105.
10. Dejda A., Sokolowska P. Nowak J. Z. (2005) Neuroprotective potential of three neuropeptides PACAP, VIP and PHI. Pharmacol Rep. 57, 307 320.
11. Delghandi M. P., Johannessen M. Moens U. (2005) The cAMP signalling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells. Cell. Signal. 17, 1343 1351.
12. DiCicco-Bloom E. Deutsch P. J. (1992) Pituitary adenylate cyclase activating polypeptide (PACAP) potently stimulates mitosis, neuritogenesis and survival in cultured rat sympathetic neuroblasts. Regul. Pept. 37, 319 325.
13. Dickinson T., Fleetwood-Walker S. M., Mitchell R. Lutz E. M. (1997) Evidence for roles of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) receptors in modulating the responses of rat dorsal horn neurons to sensory inputs. Neuropeptides 31, 175 181.
14. Dugan L. L., Kim J. S., Zhang Y., Bart R. D., Sun Y., Holtzman D. M. Gutmann D. H. (1999) Differential effects of cAMP in neurons and astrocytes. Role of B-Raf. J. Biol. Chem. 274, 25842 25848.
15. Dumaz N. Marais R. (2005) Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft fur Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS meeting in Brussels. FEBS J. 272, 3491 3504.
16. Ebisuya M., Kondoh K. Nishida E. (2005) The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity. J. Cell Sci. 118, 2997 3002.
17. Encinas M., Iglesias M., Llecha N. Comella J. X. (1999) Extracellular-regulated kinases and phophatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y. J. Neurochem. 73, 1409 1421.
18. Falluel-Morel A., Vaudry D., Aubert N., Galas L., Benard M., Basille M., Fontaine M., Fournier A., Vaudry H. Gonzalez B. J. (2005) Pituitary adenylate cyclase-activating polypeptide prevents the effects of ceramides on migration, neurite outgrowth, and cytoskeleton remodeling. Proc. Natl Acad. Sci. U. S. A. 102, 2637 2642.
19. Farkas O., Tamas A., Zsombok A., Reglodi D., Pal J., Buki A., Lengvari I., Povlishock J. T. Doczi T. (2004) Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury. Regul. Pept. 123, 69 75.
20. Feng Z. Porter A. G. (1999) NF-kappaB/Rel proteins are required for neuronal differentiation of SH-SY5Y neuroblastoma cells. J. Biol. Chem. 274, 30341 30344.
21. Feschenko M. S., Stevenson E., Nairn A. C. Sweadner K. J. (2002) A novel cAMP-stimulated pathway in protein phosphatase 2A activation. J. Pharmacol. Exp. Therap. 302, 111 118.
22. Gerdin M. J. Eiden L. E. (2007) Regulation of PC12 cell differentiation by cAMP signaling to ERK independent of PKA: Do all the connections add up? Sci. STKE 2007, pe15.
23. Gonzalez B. J., Basille M., Vaudry D., Fournier A. Vaudry H. (1997) Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts. Neuroscience 78, 419 430.
24. Guirland C., Buck K. B., Gibney J. A., DiCicco-Bloom E. Zheng J. Q. (2003) Direct cAMP signaling through G-protein-coupled receptors mediates growth cone attraction induced by pituitary adenylate cyclase-activating polypeptide. J. Neurosci. 23, 2274 2283.
25. Hanada M., Krajewski S., Tanaka S., Cazals-Hatem D., Spengler B. A., Ross R. A., Biedler J. L. Reed J. C. (1993) Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. Cancer Res. 53, 4978 4986.
26. Harmar A. J. (2001) Family-B G-protein-coupled receptors. Genome Biol. 2:reviews, 3013.1 3013.10.
27. Harmar T. Lutz E. (1994) Multiple receptors for PACAP and VIP. Trends Pharmacol. Sci. 15, 97 99.
28. Harrington M. E., Hoque S., Hall A., Golombek D. Biello S. (1999) Pituitary adenylate cyclase activating peptide phase shifts circadian rhythms in a manner similar to light. J. Neurosci. 19, 6637 6642.
29. Hashimoto H., Kunugi A., Arakawa N. et al. (2003) Possible involvement of a cyclic AMP-dependent mechanism in PACAP-induced proliferation and ERK activation in astrocytes. Biochem. Biophys. Res. Commun. 311, 337 343.
30. Héraud C., Hilairet S., Muller J.-M., Leterrier J.-F. Chadéneau C. (2004) Neuritogenesis induced by vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and peptide histidine methionine in SH-SY5Y cells. J. Neurosci. Res. 75, 320 329.
31. Inoue M., Fujishiro N., Ogawa K., Muroi M., Sakamoto Y., Imanaga I. Shioda S. (2000) Pituitary adenylate cyclase-activating polypeptide may function as a neuromodulator in guinea-pig adrenal medulla. J. Physiol. 528, 473 487.
32. Jamsa A., Hasslund K., Cowburn R. F., Backstrom A. Vasange M. (2004) The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation. Biochem. Biophys. Res. Commun. 319, 993 1000.
33. Kiermayer S., Biondi R. M., Imig J., Plotz G., Haupenthal J., Zeuzem S. Piiper A. (2005) Epac activation converts cAMP from a proliferative into a differentiation signal in PC12 cells. Mol. Biol. Cell 16, 5639 5648.
34. Kim W. K., Kan Y., Ganea D., Hart R. P., Gozes I. Jonakait G. M. (2000) Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway. J. Neurosci. 20, 3622 3630.
35. Laburthe M., Couvineau A. Marie J. C. (2002) VPAC receptors for VIP and PACAP. Receptors Channels 8, 137 153.
36. 2 +]i and cyclic AMP in CHO cells expressing Galpha16. Cell Calcium 30, 229 234.
37. Leemhuis J., Boutillier S., Schmidt G. Meyer D. K. (2002) The protein kinase inhibitor H89 acts on cell morphology by inhibiting Rho kinase. J. Pharmacol. Exp. Ther. 300, 1000 1007.
38. Leli U., Cataldo A., Shea T. B., Nixon R. A. Hauser G. (1992) Distinct mechanisms of differentiation of SH-SY5Y neuroblastoma cells by protein kinase C activators and inhibitors. J. Neurochem. 58, 1191 1198.
39. Lin S. L., Johnson-Farley N. N., Lubinsky D. R. Cowen D. S. (2003) Coupling of neuronal 5-HT7 receptors to activation of extracellular-regulated kinase through a protein kinase A-independent pathway that can utilize Epac. J. Neurochem. 87, 1076 1085.
40. 1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP. Mol. Cell. Neurosci. 31, 193 201.
41. MacKenzie C. J., Lutz E. M., Johnson M. S., Robertson D. N., Holland P. J. Mitchell R. (2001) Mechanisms of phospholipase C activation by the vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide type 2 receptor. Endocrinology 142, 1209 1217.
42. May V. Braas K. M. (1995) Pituitary adenylate cyclase-activating polypeptide (PACAP) regulation of sympathetic neuron neuropeptide Y and catecholamine expression. J. Neurochem. 65, 978 987.
43. McCulloch D., Lutz E. M., Johnson M. S., Robertson D. N., MacKenzie C. J., Holland P. J. Mitchell R. (2001) ADP-ribosylation factor-dependent phospholipase D activation by VPAC receptors and a PAC(1) receptor splice variant. Mol. Pharmacol. 59, 1523 1532.
44. McLees A., Graham A., Malarkey K., Gould G. W. Plevin R. (1995) Regulation of lysophophatidic acid-stimulated tyrosine phosphorylation of mitogen-activated protein kinase by protein kinase C- and pertussis toxin-dependent pathways in the endothelial cell line EAhy 926. Biochem. J. 307, 743 748.
45. Meiri K. F., Pfenninger K. H. Willard M. B. (1986) Growth-associated protein, GAP-43, a polypeptide that is induced when neurons extend axons, is a component of growth cones and corresponds to pp46, a major polypeptide of a subcellular fraction enriched in growth cones. Proc. Natl Acad. Sci. USA 83, 3537 3541.
46. Miyata A., Arimura A., Dahl R. R., Minamino N., Uehara A., Jiang L., Culler M. D. Coy D. H. (1989) Isolation of a novel 38 residue-hypothalmic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164, 567 574.
47. Moller K., Reimer M., Ekblad E., Hannibal J., Fahrenkrug J., Kanje M. Sundler F. (1997) The effects of axotomy and preganglionic denervation on the expression of pituitary adenylate cyclase activating peptide (PACAP), galanin and PACAP type 1 receptors in the rat superior cervical ganglion. Brain Res. 775, 166 182.
48. Moro O., Wakita K., Ohnuma M., Denda S., Lerner E. A. Tajima M. (1999) Functional characterization of structural alterations in the sequence of the vasodilatory peptide maxadilan yields a pituitary adenylate cyclase-activating peptide type 1 receptor-specific antagonist. J. Biol. Chem. 274, 23103 23110.
49. Onoue S., Endo K., Yajima T. Kashimoto K. (2002) Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide attenuate glutamate-induced nNOS activation and cytotoxicity. Regul. Pept. 107, 43 47.
50. Påhlman S., Ruusala A.-I., Abrahamsson L., Mattsson M. E. K. Esscher T. (1984) Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbol ester-induced differentiation. Cell Differ. 14, 135 144.
51. Påhlman S., Mamaeva S., Meyerson G., Mattson M. E. K., Bjelfman C., Örtoft E. Hammerling U. (1990) Human neuroblastoma cells in culture: a model for neuronal cell differentiation and function. Acta Physiol. Scand. Suppl. 592, 25 37.
52. Pan J., Kao Y. L., Joshi S., Jeetendran S., Dipette D. Singh U. S. (2005) Activation of Rac1 by phosphatidylinositol 3-kinase in vivo: role in activation of mitogen-activated protein kinase (MAPK) pathways and retinoic acid-induced neuronal differentiation of SH-SY5Y cells. J. Neurochem. 93, 571 583.
53. Raguenez G., Desire L., Lantrua V. Courtois Y. (1999) BCL-2 is upregulated in human SH-SY5Y neuroblastoma cells differentiated by overexpression of fibroblast growth factor 1. Biochem. Biophys. Res. Commun. 258, 745 751.
54. Ravni A., Bourgault S., Lebon A., Chan P., Galas L., Fournier A., Vaudry H., Gonzalez B., Eiden L. E. Vaudry D. (2006) The neurotrophic effects of PACAP in PC12 cells: control by multiple transduction pathways. J. Neurochem. 98, 321 329.
55. Rich T. C., Fagan K. A., Tse T. E., Schaack J., Cooper D. M. Karpen J. W. (2001) A uniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell. Proc. Natl Acad. Sci. USA 98, 13049 13054.
56. Sánchez S., Jiménez C., Carrera A. C., Diaz-Nido J., Avila J. Wandosell F. (2004) A cAMP-activated pathway, including PKA and PI3K, regulates neuronal differentiation. Neurochem. Int. 44, 231 242.
57. Shi G.-X., Rehmann H. Andres D. A. (2006) A novel cAMP-dependent Epac-Rit signaling pathway contributes to PACAP38-mediated neuronal differentiation. Mol. Cell. Biol. 26, 9136 9147.
58. Spengler D., Waeber C., Pantaloni C., Holsboer F., Bockaert J., Seeburg P. H. Journot L. (1993) Differential signal transduction by 5 splice variants of the PACAP receptor. Nature 365, 170 175.
59. Stephens R. M., Sithanandam G., Copeland T. D., Kaplan D. R., Rapp U. R. Morrison D. K. (1992) 95-kilodalton B-Raf serine/threonine kinase: identification of the protein and its major autophosphorylation site. Mol. Cell. Biol. 12, 3733 3742.
60. Strack S. (2002) Overexpression of the protein phosphatase 2A regulatory subunit Bgamma promotes neuronal differentiation by activating the MAP kinase (MAPK) cascade. J. Biol. Chem. 277, 41525 41532.
61. Suarez V., Guntinas-Lichius O., Streppel M., Ingorokva S., Grosheva M., Neiss W. F., Angelov D. N. Klimaschewski L. (2006) The axotomy-induced neuropeptides galanin and pituitary adenylate cyclase-activating peptide promote axonal sprouting of primary afferent and cranial motor neurones. Eur. J. Neurosci. 24, 1555 1564.
62. Tamas A., Zsombok A., Farkas O., Reglodi D., Pal J., Buki A., Lengvari I., Povlishock J. T. Doczi T. (2006) Postinjury administration of pituitary adenylate cyclase activating polypeptide (PACAP) attenuates traumatically induced axonal injury in rats. J. Neurotrauma 23, 686 695.
63. Traverse S., Gomez N., Paterson H., Marshall C. Cohen P. (1992) Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288, 351 355.
64. Vaudry D., Gonzalez B. J., Basille M., Fournier A. Vaudry H. (1999) Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development. Proc. Natl. Acad. Sci. USA 96, 9415 9420.
65. Vaudry D., Gonzalez B. J., Basille M., Yon L., Fournier A. Vaudry H. (2000) Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol. Rev. 52, 269 324.
66. Villalba M., Bockaert J. Journot L. (1997) Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway. J. Neurosci. 17, 83 90.
67. Yin F., Wang Y. Y., Du J. H., Li C., Lu Z. Z., Han C. Zhang Y. Y. (2006) Noncanonical cAMP pathway and p38 MAPK mediate beta2-adrenergic receptor-induced IL-6 production in neonatal mouse cardiac fibroblasts. J. Mol. Cell. Cardiol. 40, 384 393.
68. Yuhara A., Ishii K., Nishio C., Abiru Y., Yamada M., Nawa H., Hatanaka H. Takei N. (2003) PACAP and NGF cooperatively enhance choline acetyltransferase activity in postnatal basal forebrain neurons by complementary induction of its different mRNA species. Biochem. Biophys. Res. Commun. 301, 344 349.
69. 2 + interplay: a matter of oscillation patterns. Trends Neurosci. 26, 53 55.
70. Zhang Q., Shi T.-J., Ji R.-R., Zhang Y.-T., Sundler F., Hannibal J., Fahrenkrug J. Hokfelt T. (1995) Expression of pituitary adenylate cyclase-activating polypeptide in dorsal root ganglia following axotomy: time course and coexistence. Brain Res. 705, 149 158.
71. Zhang Y.-Z., Hannibal J., Zhao Q., Moller K., Danielsen N., Fahrenkrug J. Sundler F. (1996) Pituitary adenylate cyclase activating peptide expression in the rat dorsal root ganglia: up-regulation after peripheral nerve injury. Neuroscience 74, 1099 1110.
72. Zhou C. J., Shioda S., Yada T., Inagaki N., Pleasure S. J. Kikuyama S. (2002) PACAP and its receptors exert pleiotropic effects in the nervous system by activating multiple signaling pathways. Curr. Protein Pept. Sci. 3, 423 439.